Dynamic Healthcare buys LIS firm Dynacor
Dynamic Healthcare buys LIS firm DynacorDynamic Healthcare Technologies has acquired laboratory information systems vendor Dynacor in a deal that broadens Dynamic's position in the LIS market and increases its customer base to over 600
Dynamic Healthcare buys LIS firm Dynacor
Dynamic Healthcare Technologies has acquired laboratory information systems vendor Dynacor in a deal that broadens Dynamic's position in the LIS market and increases its customer base to over 600 hospitals, according to the company.
Under the terms of the deal, Dynamic exchanged 250,000 shares of Dynamic stock for all outstanding shares of Dynacor. Dynamic, based in Maitland, FL, intends to combine the strengths of Dynamic's LabPro 2000 and Dynacor's Premier Series LIS, and will integrate marketing efforts with Dynamic's CoPath Client/Server product, which was released in March.
In other Dynamic news, the company reported record quarterly revenues in its first quarter (end-March) of $9.7 million, a 319% increase over the $3 million posted for the same period in 1996. Much of the company's revenue increase came from a boom in application software licensing revenue, which jumped from $270,000 in the first quarter of 1996 to $5.1 million in the first quarter of 1997. Net income was $3 million, compared with a loss of $367,000 for Q1 1996.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
